Genetics of Middle Ear Disease
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The goal of this study is to identify the genes that contribute to susceptibility to recurrent/persistent middle ear disease. Five hundred families with at least 2 children who have undergone tympanostomy tube insertion will be enrolled. A blood sample will be obtained from the children who had tubes and any available parent (at least 1), as well as any siblings without significant histories of middle ear disease.
| Condition |
|---|
|
Otitis Media |
| Study Type: | Observational |
| Study Design: | Observational Model: Family-Based Time Perspective: Cross-Sectional |
| Official Title: | Genetic Epidemiology of Otitis Media |
Blood samples, DNA
| Enrollment: | 2121 |
| Study Start Date: | July 2002 |
| Study Completion Date: | July 2009 |
| Primary Completion Date: | July 2007 (Final data collection date for primary outcome measure) |
Using the twin study approach, the investigators demonstrated that time with middle ear effusion (MEE), number of episodes of MEE and numbers of episodes of acute otitis media (AOM) have a strong genetic component. The point estimate of heritability of time with MEE was 0.73. While there is significant evidence that susceptibility to recurrent/persistent OM is largely genetically determined, the specific genes which confer susceptibility are unknown. The overall research strategy to identify genes underlying OM is to apply a three-stage study design that will allow the investigators to balance cost efficiency with statistical power. Five hundred evaluable pairs of siblings with a history of tympanostomy tube insertion (affected), their parent(s) and available non-affected full siblings will be recruited. A blood sample will be obtained from each subject for genotyping.
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Families with 2 or more full sibs who had tympanostomy tubes inserted
Inclusion Criteria:
- families: 2 or more full sibs who had tympanostomy tubes inserted
Exclusion Criteria:
- major congenital malformations
- medical conditions with a predisposition for OM (e.g. cleft palate, Down syndrome, or other craniofacial malformations
- cared for in the Intensive Care Unit as neonate
- been on assisted ventilation
- known sensorineural hearing loss
Contacts and Locations| United States, Pennsylvania | |
| ENT Research Center, Children's Hospital of Pittsburgh of UPMC | |
| Pittsburgh, Pennsylvania, United States, 15224 | |
| Principal Investigator: | Margaretha L Casselbrant, MD, PhD | Children's Hospital of Pittsburgh |
More Information
Publications:
| Responsible Party: | Margaretha Casselbrant, Principal Investigator, Children's Hospital of Pittsburgh |
| ClinicalTrials.gov Identifier: | NCT00422136 History of Changes |
| Other Study ID Numbers: | R01 DC05630, R01DC005630 |
| Study First Received: | January 12, 2007 |
| Last Updated: | November 11, 2011 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Children's Hospital of Pittsburgh:
|
middle ear otitis genetics |
Additional relevant MeSH terms:
|
Otitis Otitis Media Ear Diseases Otorhinolaryngologic Diseases |
ClinicalTrials.gov processed this record on May 22, 2013